Tag: mustang bio
December 9, 2019
Mustang Bio Announces Additional Clinical Data on MB-107
The company announced that updated Phase 1/2 clinical data for MB-107 was presented at the 61st American Society of Hematology... August 27, 2019
Mustang Bio Announces License Agreement with CSL Behring
Mustang Bio (NASDAQ:MBIO) has announced it has entered into a license agreement with CSL Behring for the Cytegrity stable producer... August 22, 2019
Mustang Bio and St. Jude Children’s Research Hospital Receives RMAT Designation from FDA
Mustang Bio (NASDAQ:MBIO) and St. Jude Children’s Research hospital have announced that MB-107, a gene therapy to treat X-linked severe...
August 18, 2019
5 Top Weekly NASDAQ Biotech and Pharma Stocks: Novavax Up 82 Percent
Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have... August 13, 2019
Mustang Bio Announces $9.28 Million Grant to Fund Phase 1 Trial of CAR T Therapy MB-103
Mustang Bio (NASDAQ:MBIO) has announced a US$9.28 million grant from the California Institute for Regenerative Medicine (CIRM) to fund an... July 24, 2019
Mustang Bio Receives Orphan Drug Designation for MB-102
Mustang Bio (NASDAQ:MBIO) announced it has received orphan drug designation from the US Food and Drug Administration (FDA) For its... May 8, 2019